Private: Equity Firms Buying Medical Practices

: Declining reimbursements and the high cost of shifting to Value-Based Care (VBC) models make the financial backing of a large firm attractive. 3. The Impact: Cost, Quality, and Autonomy

The rapid consolidation of independent medical practices under private equity ownership. private equity firms buying medical practices

After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management. : Declining reimbursements and the high cost of

: Most deals are now "bolt-ons"—small practices acquired to expand existing large platforms—which often fall below federal reporting thresholds, leading to "stealth consolidation". 2. The Driver: Why Doctors are Selling After a period of stabilization, healthcare private equity

: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics.

Popular
Trending
Tags
Models
Channels
Favorites
History

: Declining reimbursements and the high cost of shifting to Value-Based Care (VBC) models make the financial backing of a large firm attractive. 3. The Impact: Cost, Quality, and Autonomy

The rapid consolidation of independent medical practices under private equity ownership.

After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management.

: Most deals are now "bolt-ons"—small practices acquired to expand existing large platforms—which often fall below federal reporting thresholds, leading to "stealth consolidation". 2. The Driver: Why Doctors are Selling

: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics.

private equity firms buying medical practices